|Bid||44.00 x 1300|
|Ask||44.22 x 3200|
|Day's range||43.25 - 44.14|
|52-week range||32.83 - 44.14|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||22.27|
|Earnings date||25 Oct 2021 - 29 Oct 2021|
|Forward dividend & yield||1.56 (3.98%)|
|Ex-dividend date||29 Jul 2021|
|1y target est||42.97|
Yahoo Finance’s Ines Ferre reports on the day's trending tickers.
Talks of booster shots for the COVID-19 vaccines have been gaining traction over recent weeks with case counts rising and new variants emerging.
(Bloomberg) -- Seventy percent of U.S. adults have received at least one dose of a Covid-19 vaccine, a key milestone in the fight against the pandemic that comes almost a month later than President Joe Biden’s original goal.The head of the U.S. Food and Drug Administration division reviewing Pfizer Inc.’s application for full approval of its vaccine said the agency is working quickly on the issue as the country experiences a “very real fourth wave.” San Francisco and its surrounding counties rei